Are you a new member? Sign up now
Login area
| Sign up
close
ADOL - 500mg - 24
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N02BE01 | G | Paracetamol - 500mg | 3740 | 78846/98 | ADOL | 500mg | 24 | Caplet | Oral | Pharmanet Drugstore S.A.R.L. | Julphar | United Arab Emirates | 81,974 L.L | 23.08 | A1 | 2/5/2024 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N02BE01 | B | Paracetamol - 500mg | 7434 | 185997/13 | DOLIPRANE | 500mg | 16 | Tablet | Oral | Mersaco | Sanofi Winthrop Industrie | France | 120,946 L.L | 23.08 | A1 | Sanofi Aventis | France | 2/5/2024 | 0 |
| N02BE01 | B | Paracetamol - 500mg | 11332 | 146221/1 | DOLIPRANE | 500mg | 16 | Tablet | Oral | Mersaco | Opella Healthcare International SAS | France | 120,946 L.L | 23.08 | A1 | Opella Healthcare France SAS | France | 2/5/2024 | 0 |
| N02BE01 | B | Paracetamol - 500mg | 9941 | 49819/1 | PANADOL ADVANCE | 500mg | 96 | Tablet, film coated | Oral | Sadco | GlaxoSmithKline Dungarvan Ltd | Ireland | 438,093 L.L | 23.08 | A1 | GlaxoSmithKline Consumer Healthcare (Ireland) Ltd | Ireland | 2/5/2024 | 0 |
| N02BE01 | B | Paracetamol - 500mg | 9945 | 49619/1 | PANADOL ADVANCE | 500mg | 24 | Tablet, film coated | Oral | Sadco | GlaxoSmithKline Dungarvan Ltd | Ireland | 137,072 L.L | 23.08 | A1 | GlaxoSmithKline Consumer Healthcare (Ireland) Ltd | Ireland | 2/5/2024 | 0 |
| N02BE01 | B | Paracetamol - 500mg | 9947 | 49719/1 | PANADOL ADVANCE | 500mg | 72 | Tablet, film coated | Oral | Sadco | GlaxoSmithKline Dungarvan Ltd | Ireland | 361,494 L.L | 23.08 | A1 | GlaxoSmithKline Consumer Healthcare (Ireland) Ltd | Ireland | 2/5/2024 | 0 |
| N02BE01 | G | Paracetamol - 500mg | 7307 | 96597/12 | DOLOPAN | 500mg | 24 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 135,664 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| N02BE01 | G | Paracetamol - 500mg | 10441 | 173219/1 | DOLOPAN | 500mg | 60 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 317,403 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| N02BE01 | G | Paracetamol - 500mg | 10750 | 105221/1 | DOLOPAN | 500mg | 72 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 380,115 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| N02BE01 | G | Paracetamol - 500mg | 10797 | 3722/1 | DOLOPAN | 500mg | 60 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Manufactured by Benta Lyon, France for Benta SAL | Lebanon | 317,403 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| N02BE01 | G | Paracetamol - 500mg | 10669 | 70821/1 | FEBRADOL | 500mg | 100 | Tablet | Oral | Pharmaline S.A.L. | Pharmaline SAL | Lebanon | 327,642 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| N02BE01 | G | Paracetamol - 500mg | 10198 | 5520/1 | NOMAL | 500mg | 100 | Tablet | Oral | Pharmadex | Pharmadex | Lebanon | 305,884 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| N02BE01 | G | Paracetamol - 500mg | 4535 | 26510 | PAINOL | 500mg | 20 | Tablet | Oral | Mephico S.A.L. | Mephico SAL | Lebanon | 95,989 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| N02BE01 | G | Paracetamol - 500mg | 4537 | 77/95 | PARACETAMOL | 500mg | 500 | Tablet | Oral | Mephico S.A.L. | Mephico SAL | Lebanon | 1,873,700 L.L | 23.08 | B | 2/5/2024 | 0 | ||
| N02BE01 | G | Paracetamol - 500mg | 4617 | 2723 | PARACETAMOL | 500mg | 20 | Tablet | Oral | Pharmadex | Pharmadex | Lebanon | 66,552 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| N02BE01 | G | Paracetamol - 500mg | 10197 | 35620/1 | PARACETAMOL | 500mg | 1000 | Tablet | Oral | Pharmadex | Pharmadex | Lebanon | 3,161,230 L.L | 23.08 | B | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024